Maravai LifeSciences Announces Pricing of an Upsized Secondary Offering of Class A Common Stock by Selling Stockholders

SAN DIEGO, April 07, 2021 (GLOBE NEWSWIRE) — Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services
to researchers and biotech innovators, today announced the pricing of an upsized public offering of 18,000,000 shares of Maravai’s Class A common stock by certain selling stockholders that was
previously announced, at a public offering